The global market for Microplate Systems is projected to reach US$950 million by 2025, driven by growing applications in life sciences/biotechnology research, pharmaceutical drug development, food safety testing and clinical diagnostics. Few of the macro factors priming these end-use markets for higher growth and technology adoption include rising healthcare burden shaped by growing population, aging population, spread of infectious diseases, rising prevalence of chronic lifestyle diseases, need for newer more effective drugs, and the resulting increase in healthcare R&D investments. Microplate systems are ubiquitous laboratory equipment comprising microplates, microplate readers, and microplate handling equipment. They play a key role in automation of bioassays encompassing biochemical and cell-based assays. High Throughput Screening (HTS) utilize microplates. Clinical laboratories in this era of digital health are rapidly migrating towards the use of specialized, electronic laboratory equipment, instruments and analytical tools. Poised to benefit in this regard are innovative microplate systems such as multimode readers capable of measuring photometry, fluorometry, luminometry, time-resolved fluorometry with flexibility and high performance. The miniaturization trend sweeping through the electronics industry is resulting in the development of microplates in small factors. This is an important development given the increasing miniaturization of biological assays. Benefits of performing automated assays at the nanoliter scale include process efficiency, increase in productivity, reduced labor and resource utilization, higher speed and quality of data acquisition. All of these benefits are vital in the pharmaceutical industry which is today feeling all of the challenges of declining productivity and diminishing returns on investment. Microplates with microwells are therefore growing in demand for use in miniaturized assay development and screening in modern drug discovery. Read More…